Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE
6.1.2 INCREASING INCIDENCE OF CHRONIC DISEASES
6.1.3 GOVERNMENT FUNDS IN R&D INVESTMENTS
6.1.4 ADVANCEMENT OF TECHNOLOGY IN CLINICAL TRIALS SUPPLIES
6.2 RESTRAINTS
6.2.1 ADVERSE EFFECTS OF CLINICAL TRIALS
6.2.2 TRANSPORTATION ISSUE IN CLINICAL TRIAL SUPPLIES
6.2.3 HIGH COST ASSOCIATED WITH THE CLINICAL TRIALS
6.3 OPPORTUNITIES
6.3.1 INCREASING NEW DRUG DEVELOPMENT TRIALS IN EMERGING COUNTRIES
6.3.2 INCREASING DEMAND FOR INNOVATIVE SOLUTIONS IN CLINICAL TRIALS SERVICES
6.3.3 EVOLUTION IN SUPPLY CHAIN MANAGEMENT FOR CLINICAL TRIALS
6.4 CHALLENGES
6.4.1 LOWER PROCEDURE TIME OF CLINICAL TRIALS APPROVAL
6.4.2 LACK OF SKILLED PERSON TO OPERATE DEVICES DURING CLINICAL TRIALS
7 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES
7.1 OVERVIEW
7.2 STORAGE
7.3 MANUFACTURING
7.4 PACKAGING AND LABELLING
7.5 DISTRIBUTION
8 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASES
8.1 OVERVIEW
8.2 PHASE III
8.3 PHASE II
8.4 PHASE IV
8.5 PHASE I
9 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE
9.1 OVERVIEW
9.2 ONCOLOGY
9.3 CARDIOVASCULAR DISEASES
9.4 DERMATOLOGY
9.5 METABOLIC DISORDERS
9.6 INFECTIOUS DISEASES
9.7 RESPIRATORY DISEASES
9.8 CNS AND MENTAL DISORDERS
9.9 BLOOD DISORDERS
9.1 OTHERS
10 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER
10.1 OVERVIEW
10.2 CONTRACT RESEARCH ORGANIZATIONS
10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY REGION
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.1.5.1 PARTNERSHIP
14.2 ALMAC GROUP
14.2.1 COMPANY SNAPSHOT
14.2.2 COMPANY SHARE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 CATALENT INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 SERVICE PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.3.5.1 SERVICE EXPANSION
14.4 CLINIGEN GROUP PLC
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.4.5.1 PARTNERSHIP
14.5 MOVIANTO
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 SERVICE PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.5.4.1 ACQUISITION
14.6 PCI PHARMA SERVICES
14.6.1 COMPANY SNAPSHOT
14.6.2 SERVICE PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 SHARP
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 ALIUM MEDICAL LIMITED
14.8.1 COMPANY SNAPSHOT
14.8.2 SERVICE PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 ANCILLARE, LP
14.9.1 COMPANY SNAPSHOT
14.9.2 SERVICE PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 BIOCAIR
14.10.1 COMPANY SNAPSHOT
14.10.2 SERVICE PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 BIONICAL LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 SERVICE PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.11.3.1 SERVICE LAUNCH
14.12 CLINICAL SUPPLIES MANAGEMENT HOLDINGS,INC
14.12.1 COMPANY SNAPSHOT
14.12.2 SERVICE PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 KLIFO
14.13.1 COMPANY SNAPSHOT
14.13.2 SERVICE PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.13.3.1 ACQUISTION
14.14 MYONEX
14.14.1 COMPANY SNAPSHOT
14.14.2 SERVICE PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 PAREXEL INTERNATIONAL CORPORATION
14.15.1 COMPANY SNAPSHOT
14.15.2 SERVICE PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.15.3.1 COLLABORATION
14.16 SIRO CLINPHARM PRIVATE LIMITED
14.16.1 COMPANY SNAPSHOT
14.16.2 SERVICE PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 LOCATIONS OF REGISTERED STUDIES
TABLE 2 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA STORAGE IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA MANUFACTURING IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA PACKAGING AND LABELLING IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA DISTRIBUTION IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA PHASE III IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA PHASE II IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA PHASE IV IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA PHASE I IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA ONCOLOGY IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA CARDIOVASCULAR DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA DERMATOLOGY IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA METABOLIC DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA INFECTIOUS DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA RESPIRATORY DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA CNS AND MENTAL DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA BLOOD DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA OTHERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 30 U.S. CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 31 U.S. CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 32 U.S. CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 33 U.S. CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 35 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 36 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 37 CANADA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 39 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 40 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 41 MEXICO CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA CLINICAL TRIAL SUPLLIES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CLINICAL TRIAL SUPLLIES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE AND INCREASING INCIDENCES OF DISEASES IS DRIVING THE NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 STORAGE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET
FIGURE 14 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, 2021
FIGURE 15 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, LIFELINE CURVE
FIGURE 18 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, 2021
FIGURE 19 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, 2021
FIGURE 23 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY END USER, 2021
FIGURE 27 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: SNAPSHOT (2021)
FIGURE 31 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2021)
FIGURE 32 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES (2022-2029)
FIGURE 35 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET: COMPANY SHARE 2021 (%)
